Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Show all 514 references

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

Items 501–600 of 806

Reverse Remodeling Following Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: As Transformed as Otto’s Heart?
Shen, L., & Wong, T. C. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.018959
Significance of the Monitoring Right Ventricular Echocardiographic Parameters in Patients with Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation—A Single-Center Experience
Porubän, T., Schusterová, I., Pella, D., Fedačko, J., Uchnar, K. A. S., Sepešiová, B., & Gurbalova, S. (2025) · Diagnostics · doi:10.3390/diagnostics15192509
(Sudden cardiac death in hypertrophic cardiomyopathy)
Jenšovský, M., Puchnerová, V., Ošťádal, P., & Bonaventura, J. (2025) · Cor et Vasa · doi:10.33678/cor.2025.086
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy
Lee, H. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.008
The 65-year story of hypertrophic cardiomyopathy: its surgical treatment with global perspectives and the controversial evolution of left ventricular outflow obstruction
Maron, B. J., & Maron, M. S. (2025) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-025-02062-y
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines
Yaman, A. E., Shaikh, A., Sayed, A., Alwan, M., Ghazawi, A. E., Rifai, M. A., & Al-Mallah, M. H. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01341-8
Transplanting Against the Gradient: Invasive Evaluation of Resting and Dynamic Left Ventricular Outflow Tract (LVOT) Obstruction in a Liver Transplant Candidate
Slifirski, H., Weinberg, L., Raykateeraroj, N., Suh, J. A., Koshy, A. N., & Lee, D. K. (2025) · Cureus · doi:10.7759/cureus.94656
Disopyramide Therapy in Cats with Obstructive Hypertrophic Cardiomyopathy Non-Responsive to Carvedilol
Satomi, S., Suzuki, R. H., Yuchi, Y., Kanno, H., Nomura, M., Teshima, T., & Matsumoto, H. (2025) · Veterinary Sciences · doi:10.3390/vetsci12100999
Fit Hearts, Better Outcomes? A Systematic Review and Meta-Analysis of Exercise Intensity and Peak VO2 in Hypertrophic Cardiomyopathy
Djuranovic, A., Ristić, J., Antić, M., Rajović, N., Mirkovic, M., Batinic, D., Maletic, M., Kizilkilic, S. E., Ferrara, V. Z., Prodanović, V., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217466
Entropy in Hypertrophic Cardiomyopathy: A New Layer in Risk Stratification for Sudden Cardiac Death
Lee, C., & Abraham, T. P. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.019080
Hypertrophic cardiomyopathy in workers who work in harmful working conditions: aspects of professional aptitude testing
Gorokhova, S. G., Алпаев, Д. В., Korchagin, I. A., Strizhakov, L. A., & Atkov, O. Y. (2025) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2025-65-9-602-609
Gipertrofik kardiomiopatiyaning obstruktiv shaklida yurakning remodellashuv xususiyatlari, Morrou bo’yicha mioektomiyaning samaradorligi
Rasulova, N., Абдуллаев, Т. А., & Hakimov, A. (2025) · Cardiology of Uzbekistan. · doi:10.70626/cardiouz-2025-2-58
Revisiting the concept of “phenotype” in pediatric hypertrophic cardiomyopathy using myocardial stiffness and strain variations assessed by ultrafast ultrasound imagingPreprint
Malik, A., Venet, M., Mital, S. R., Papadacci, C., Pernot, M., Friedberg, M. K., Mertens, L., Baranger, J., & Villemain, O. (2025) · medRxiv · doi:10.1101/2025.11.04.25339540
Self-citation
Arritmia Por Cardiomiopatia Hipertrófica No Contexto Do Esporte
Mentes, T. L. F., Emmerich, J. C., de Alcântra, C. E. X., Lima, L. D., da Silva, C. M., Santos, M. E., Peterle, L. Z., Bento, J. G. M., de Uzeda, J. C., da Silva, L. F. L., et al. (2025) · Editora Pasteur eBooks · doi:10.59290/1289002549
ALPK3 Cardiomyopathy: Integrative Review With Systematic Variant Curation, Mechanisms, and Translation
Chang, C., Wang, L., Chen, Z., Bogomolovas, J., & Chen, J. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005368
Non-sustained Ventricular Tachycardia in Children and Adult Congenital Heart Disease: Optimal Duration and Clinical Significance
El-Assaad, I., Dakik, L., E’mar, A. R., Heilbronner, A. K., Aziz, P. F., & Patel, A. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-04086-y
Cardiomyopathy
Salih, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-03240-9_9
Pathology and Pathophysiology
Sekimoto, T., Konishi, T., & Virmani, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_2
Pharmacologic Therapy of Hypertrophic Cardiomyopathy 1964–2024: From Beta-Blockers to Disopyramide
Sherrid, M. V., & Massera, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_18
Youth and Athletic Screening: Focus on Hypertrophic Cardiomyopathy
Dineen, E. H., & Martinez, M. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_15
Self-citation
Current Evidence in Cardiac Myosin Inhibitors and Future Directions in Medical Therapy
Desai, M. Y., Olivotto, I., & Masri, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_28
Lifestyle Modification: Diet, Exercise, Sports, and Other Issues
Friedman, E. M., & Martinez, M. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_16
Self-citation
Longitudinal analyses of healthcare resource utilization and costs among patients with obstructive hypertrophic cardiomyopathy
Reza, N., Butzner, M., Batra, K., Amos, Q., Buikema, A. R., Shreay, S., & OWENS, A. T. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2584888
A Nomogram for Predicting Residual Mitral Regurgitation in Patients With Obstructive Hypertrohpic Cardiomyopathy Undergoing Transapical Beating-Heart Septal Myecotmy
Wang, H., Zhu, Y. Y., Zhou, W., Tian, J. M., Liu, S., Cheng, X.-Q., Deng, Y., Wei, X., & Liu, Y. (2025) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaf418
Efficacy Analysis of Percutaneous Endocardial Septal Radiofrequency Ablation Guided by Ablation Index in the Treatment of Drug‐Resistant Hypertrophic Obstructive Cardiomyopathy
Zhang, H., Yang, S., Sheng, G., Gong, C., Chen, Y., Huang, Y., Hong, S., & Wang, Z. (2025) · Journal of Interventional Cardiology · doi:10.1155/joic/6658568
66-Year-Old Woman With Altered Mental Status
Ibrahim, M. G., Kennedy, T. P., & Malik, A. A. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.03.034
Genetic factors influencing clinical phenotype and electrocardiographic features in left ventricular hypertrophy
Zaklyazminskaya, E. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33927-1.00014-6
S165F mutation-induced Junctophilin-2 autoinhibition impairs Ca2+ signaling in hypertrophic cardiomyopathy
Li, Z., Wang, J., Fang, X., Liu, H., Liu, W., Zhang, W., & Li, J. (2025) · Communications Biology · doi:10.1038/s42003-025-09244-9
Reduced Kidney Function and Left Atrial Dilatation as Predictors of Incident Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Tsumaya, Y., Hayashi, K., Tsuda, T., Nomura, A., Nakade, Y., Oura, M., Yuno, T., Nakata, M., Terakami, T., Oe, H., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70232
Economic burden and therapeutic advances in obstructive hypertrophic cardiomyopathy: a changing landscape
Guida, G., Attanasio, A. F., Disabato, G., & Piepoli, M. F. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf148
Miocardiopatías
Ayestarán, N. M., González, R. G., Rodríguez, F. D., & Segovia, J. (2025) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2025.11.010
Impact of Cardiovascular Complications on the Economic Burden in Patients with Hypertrophic Cardiomyopathy
Butzner, M., Chen, M., Amonkar, S., Papademetriou, E., Potluri, R. C., Liu, X., & Abraham, T. P. (2025) · Journal of Cardiac Failure - Intersections · doi:10.1016/j.yjcafi.2025.11.002
The evolving clinical practice of septal reduction therapy in hypertrophic obstructive cardiomyopathy
Zhang, X., Xie, Y., Fang, L., Xu, J., Yang, Y., He, Z., Xiong, Y., Huang, M., Lv, Q., Xie, M., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004015
Magnetic resonance imaging evaluation of the effects of myosin inhibitors (mavacamten and aficamten) in hypertrophic cardiomyopathy: a systematic review and case report
Bernardes, C., Carvalho, J. G., Rodrigues, P., & França, M. (2025) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2025.3506
Assessment of machine learning approaches for detecting brief arrhythmias: Short-duration AF and NSVT
Vavassori, L., Saiz-Vivó, J., Schneider, R., & Corino, V. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.111201
Development, Validation, and Subtype Analysis of a Predictive Model for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Shen, A., Xu, J., Xue, Q., Yu, H., Liang, J., Yue, X., Liu, Y., & Mu, D. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45267
Novel compound heterozygous ALPK3 mutations (c.4234C>T and c.3491G>A), causing hypertrophic cardiomyopathy treated with the liwen procedure: case report
Liu, W.-J., Yang, H., Jiao, F.-H., Hu, H.-Y., Xu, W.-J., Wang, Y., Duan, L., Zhao, X., Zhang, R.-J., & Chang, C. D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1671882
Left Atrial Appendage Thrombus in Hypertrophic Cardiomyopathy With Atrial Fibrillation—Common and Resistant to Treatment
Massera, D., & Sherrid, M. V. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.047336
Aficamten Monotherapy for Hypertrophic Cardiomyopathy
Ahamed, H., Ommen, S. R., & Rowin, E. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2514558
Self-citation
Desenmascarando el gradiente oculto: el papel de la ecocardiografía de esfuerzo en la miocardiopatía hipertrófica
Ramos, N., Mirelis, J. G., & González-López, E. (2025) · REC CardioClinics · doi:10.1016/j.rccl.2025.10.004
Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions
Katsi, V. K., Papadomarkaki, K., Manousiadis, K., Triantafyllou, E., Fragoulis, C., & Tsioufis, K. P. (2025) · Diseases · doi:10.3390/diseases14010001
The cardiac myosin inhibitor era—more than treating left ventricular outflow tract obstruction in hypertrophic cardiomyopathy?
Haugaa, K. H., & Hasselberg, N. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf364
Fizyoterapi ve Rehabilitasyonda Ağrı, Egzersiz Ve Psikofizyolojik Yaklaşımlar
SARI, A., Gürses, Ö. A., Yaman, Ö. N. T., Kuzu, Ş., Dönmez, S., KAYA, M. H., Şimşek, Ş., Gökmen, G. Y., ARACI, A., Firat, M. Ö., et al. (2025) · Bidge Yayınları eBooks · doi:10.70269/ehsq1aaq1rij
BEYİN TÜMÖRÜ HASTALARINDA NÖROBİLİŞSEL KAYIPLAR VE ÇOK BİLEŞENLİ REHABİLİTASYON STRATEJİLERİ
Firat, M. Ö., & AKÇAY, İ. H. (2025) · Bidge Yayınları eBooks · doi:10.70269/10.70269/6884812525
FİZYOTERAPİ VE REHABİLİTASYONDA BÜYÜK DİL MODELLERİ KLİNİK UYGULAMALAR, EĞİTİM VE DİJİTAL REHABİLİTASYON
Gürses, Ö. A. (2025) · Bidge Yayınları eBooks · doi:10.70269/10.70269/8714494176
EGZERSİZİN KARDİYOVASKÜLER SAĞLIĞA ETKİSİ
Güneş, M., & KAVAK, M. (2025) · Bidge Yayınları eBooks · doi:10.70269/10.70269/6564154261
FIZIKSEL AKTIVITE VE FIZIKSEL UYGUNLUK
SARI, A., & TÜRKER, B. (2025) · Bidge Yayınları eBooks · doi:10.70269/10.70269/6446874943
ENGELLİLİK VE EVRENSEL TASARIM
ŞİMŞEK, Ş., & Soysal, A. N. O. (2025) · Bidge Yayınları eBooks · doi:10.70269/10.70269/5646943392
A case report of a Chinese patient with obstructive hypertrophic cardiomyopathy harboring rare variants in both the MYBPC3 and DSP genes
Wu, X.-Y., Ren, N., & Geng, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1630263
RNA-Based Therapies for Treating Monogenic Cardiomyopathies
Edwards, J. J., Edelson, J. B., & Rossano, J. W. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.12.040
Echocardiographic finding of myocardial hypertrophy leading to the genetic diagnosis of LEOPARD syndrome
Li, Y., & Xu, C. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.11.204
Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper
Joza, J. E., Philippon, F., Chew, D. S., Manlucu, J., Mondesert, B. A., Sadek, M. M., Roberts, J. D., Steinberg, C., Parkash, R., Bennett, M. T., et al. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.05.020
Fabry disease cardiomyopathy: A practical guide for cardiologists
Saleh, T. A., Qadeer, Y. K., Yue, B., Pieroni, M., Hachem, K. E., Poswar, F. D. O., Giugliani, R., Vardarli, I., Wallace, E. L., & Krittanawong, C. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103266
Self-citation
Overview of Professional Practice in Computed Tomography and Cardiac Magnetic Resonance Imaging in Brazil
Costa, I. B. S. D. S., Torreão, J. A., Fernandes, J. D. L., Trad, H. S., Liberato, G., Neto, R. S., Barberato, S. H., Pinto, I. M. F., & Senra, T. (2025) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.36660/abcimg.20250053i
Non-rheumatic calcific aortic valve disease in China: findings from the Global Burden of Disease study 2021
Tian, H., Liu, Z., He, J., Sun, K., You, Y., & Liu, K. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1664291
Local chemical ablation of myocardium via transvenous access: results of an experimental study
Sergeevichev, D., Tsydenova, A. Y., Murashov, I. S. M., Фоменко, В. В., Kuznetsova, E. V., Nazarov, V. M. N., & Romanov, A. B. R. (2026) · Patologiya krovoobrashcheniya i kardiokhirurgiya · doi:10.21688/1681-3472-2025-4-25-32
Brave new drugs, enduring old skills: why surgery still matters in the cardiac myosin inhibitor era
Ahamed, H., & Varma, P. K. (2026) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-025-02167-4
Novel off-pump ventricular septal myectomy for obstructive hypertrophic cardiomyopathy: A paradigm shift in surgical management
Li, J., Wan, S., & Wei, X. (2026) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/02184923261416148
Hypertrophic Obstructive Cardiomyopathy During Pregnancy: A Report of Two Cases
Román, P. A., Hoyos, C. M. P., Hernández, G. V., Fonseca-Marrero, C., & Peraza, R. V. (2026) · Cureus · doi:10.7759/cureus.102304
Hypertrophic Cardiomyopathy
Abusafia, M., Jadam, S., Ospina, S., & Desai, M. Y. (2026) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.11.002
When Substrate Meets Device: ICD Implantation and Therapy across the Spectrum of Cardiomyopathies
Sisti, N., Cardona, A., Lazzari, L., Fortuni, F., Santoro, A., Andreoli, C., Notaristefano, F., & Carreras, G. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70149
Concomitant Mitral Valve Surgery During Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy
Bové, T., Impens, L., Leleu, J., Timmermans, F., & François, K. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.01.013
The Adolescent Athlete and the Team Physician: A Consensus Statement. 2025 Update
Putukian, M., LeClere, L. E., Herring, S. A., Benjamin, H. J., Bennett, C., Boyajian-O’Neill, L. A., Callender, S. S., Day, M. A., Finnoff, J. T., Franks, R., et al. (2026) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000001321
SELEKTYVIŲ ŠIRDIES MIOZINO INHIBITORIŲ NAUDA SERGANTIESIEMS HIPERTROFINE KARDIOMIOPATIJA SU KAIRIOJO SKILVELIO IŠSTŪMIO TRAKTO OBSTRUKCIJA
Murmokaitė, I., & Sadauskienė, E. (2025) · Health Sciences · doi:10.35988/sm-hs.2025.273
Cardiovascular disease: Sex and gender evidence for cardiovascular disease prevention and risk factors for ischemic heart disease, heart failure, valvular disease, peripheral arterial disease; and cardiovascular disease in pregnancy
Isiadinso, I., Waheed, N., & Wenger, N. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26712-3.00018-5
Genetic insights into radiomic and proteomic changes under β1-blockers treatment in hypertensive heart disease and hypertrophic cardiomyopathy
Chen, Z., Tang, Y., Li, S., Pan, L., Wu, J., Liu, J., Ma, H., Wang, B., & Xie, K. (2026) · BMC Medicine · doi:10.1186/s12916-026-04691-5
Supraclavicular access for transvenous lead extraction
Kaczyński, M., Lech, B., Pawłowski, T., Farkowski, M. M., & Gil, R. J. (2026) · Kardiologia Polska · doi:10.33963/v.phj.111132
Evolution of Genetics, Genetic Testing, and Genotype Predictor Scores for Hypertrophic Cardiomyopathy: Phenotype Is Still King
Bos, J. M., & Ackerman, M. J. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047928
Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy
Hiruma, T., Kitamura, M., Takamisawa, I., Abe, R., Kawai, T., Funaki, T., Izumi, Y., Higuchi, R., Matsuda, J., Tokita, Y., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102595
Incremental Value of Apical Longitudinal Strain in Predicting High-Risk Apical Aneurysms in Patients with Hypertrophic Cardiomyopathy
Hu, X., Cheng, X., Bao, Y., Tian, J., Liu, S., Yang, Y., Xu, Q. H., Zhang, B., Deng, Y., Lu, Y., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16040575
In vivo cardiac diffusion tensor imaging quantifies microstructural disorganization to distinguish hypertrophic cardiomyopathy from hypertensive heart disease
Liu, Y., Dong, Z., Yin, G., Sun, P., Ma, X., Tang, Y., Zhou, P., Jia, X. I., Chen, X. Y., Aisikaier, K., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03647-3
Strain Imaging in Heart Failure
Hayes, D., Bayshtok, G., Stojanovska, J., & Bloom, M. W. (2026) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2026.01.007
Reproducibility of cardiac volumetric parameters derived from fully automatically prescribed image planes: a direct comparison to manual planning at 1.5-T and 3-T MRI
Deyerberg, K. K., Meinel, F. G., Watzke, L., Klemenz, A., Manzke, M., Gorodezky, M., Delso, G., Dalmer, A., Lorbeer, R., Zhexenova, D., et al. (2026) · European Radiology · doi:10.1007/s00330-026-12388-9
Cardiac magnetic resonance findings in two cases of hypertrophic cardiomyopathy with MYH7 and MYBPC3 variants: Limitations of genotype-based phenotypic prediction
Hayashi, H., Oda, S., Kidoh, M., Kuyama, N., Yamamoto, M., Izumiya, Y., Kuramoto, Y., Asano, Y., Tsujita, K., & Hirai, T. (2026) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2026.01.018
Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection
Anifowose, A., Tagliafierro, M., Mahdi, G., Hussein, S., Baudo, M., Caldonazo, T. M. M., Dokollari, A., Hosseini, K., Kent, W. D. T., & Hassanabad, A. F. (2026) · Medical Sciences · doi:10.3390/medsci14010109
Inherited Cardiac Conditions: Management of the Hypertrophic Cardiomyopathy Patient with Heart Failure
Sivalokanathan, S., Alsina, A. D. F., & Owens, A. T. (2026) · Springer eBooks · doi:10.1007/978-3-032-12626-9_18
Global longitudinal strain of the left ventricle of the heart in patients with both hypertrophic cardiomyopathy and stenotic lesion of the coronary arteries.
Akramova, E. G., & Akramova, Z. N. (2026) · Eurasian heart journal · doi:10.38109/2225-1685-2026-1-20-26
Diagnostic challenges of Takotsubo syndrome in the context of hypertrophic obstructive cardiomyopathy phenocopy
Bánfi‐Bacsárdi, F., Forrai, Z., Piróth, Z., & Muk, B. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-270318
Impact of Sociodemographic Characteristics on Outcomes in Obstructive Hypertrophic Cardiomyopathy
Reza, N., Butzner, M., Batra, K., Amos, Q., Buikema, A. R., Shreay, S., & Owens, A. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.044294
Low burden transthyretin cardiac amyloidosis on cardiac magnetic resonance: comprehensive phenotyping and distinction from hypertrophic phenocopies
Mengesha, B., Prabhakar, S., Small, G. R., Chih, S., Thornhill, R. E., & Paterson, D. I. (2026) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyag038
Prognostic Risk Assessment of Hypertrophic Cardiomyopathy in The Context of Sarcomere Gene Variation : Insights from Multimodal Phenotypic Characterization Using Unsupervised Clustering Approaches
Dang, L. N. K. (2025) · Tampere University Institutional Repository (Tampere University)
Myocardial Stiffness and Work Assessment in Pediatrics by Ultrafast Ultrasound Imaging
Malik, A. (2025) · TSpace (University of Toronto)
Scarce Duet in One Heartbeat: A Case Report on Yamaguchi and Myocardial Bridging
Saleh, N., Mawla, L. E., Shaito, Z., Mohammad, A. H. A., & Khalil, M. (2026) · Cureus · doi:10.7759/cureus.104531
Update zur hypertrophen Kardiomyopathie
Rieth, A. J., & Seidler, T. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02064-x
Comparison of temporal changes in left atrial and left ventricular strain after septal myectomy, alcohol septal ablation, and cardiac myosin inhibitorPreprint
Hwang, I., Bak, M., Park, J., Kim, S. Y., Jung, J. C., Choi, H., Chang, H. W., Lee, J. H., Yoon, Y. E., Je, H. G., et al. (2026) · medRxiv · doi:10.64898/2026.03.02.26347409
Self-citation
Three-dimensional echocardiography-derived myocardial mechanistic insights into obstructive hypertrophic cardiomyopathy with moderate septal hypertrophy
Bao, Y., Zhou, W., Tian, J., Geske, J. B., Fang, S., Liu, S., Xia, L., Deng, Y., & Liu, Y. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02257-8
2. Current developments in the diagnosis and treatment of hypertrophic cardiomyopathy
Akita, K., & Maekawa, Y. (2025) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.114.429
Access Challenges for Septal Reduction Therapy Among Individuals With Obstructive Hypertrophic Cardiomyopathy
OWENS, A. T., Schuler, P. A., Jiang, J. Z., Han, X., Hernandez, E. M., Anderson, A. J., Fang, Y., Steffens, A., & Dubey, A. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.041231
Physical activity in hypertrophic cardiomyopathy: from proscription to prescription
Temporelli, P. L., & Zuin, M. (2026) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suag051
Midsystolic Doppler Signal Void Identifies Midapical Obstruction in Hypertrophic Cardiomyopathy
Wang, Z., Liu, W., Li, W., Tao, W., Chen, J., Ye, W., Dong, Z., Wang, S., Zhou, B., Yan, M., et al. (2026) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2026.03.007
The Genetic Architecture of Sudden Cardiac Death: A State-of-the-Art Review
Montuoro, S., Monda, E., Diana, G., Bobbio, E., Fico, V., Rubino, M., Caiazza, M., Fusco, A., Cirillo, A., Verrillo, F., et al. (2026) · Cardiogenetics · doi:10.3390/cardiogenetics16010006
Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Gao, Y., Fan, Y., Cheng, X.-Q., Huang, P., Liu, H., Bi, X., Sun, J., Zhu, Y., Zhou, W., Liu, Y., et al. (2026) · Clinical Cardiology · doi:10.1002/clc.70276
Transesophageal Echocardiography in Hypertrophic Obstructive Cardiomyopathy: The Linchpin of Precision Perioperative Management
Kumar, B., & Shivganesh, D. (2026) · Journal of Perioperative Echocardiography · doi:10.5005/jp-journals-10034-1146
Multimodality Imaging in Hypertrophic Cardiomyopathy
Peters, M. G., Schweitzer, M., & Galazka, P. Z. (2026) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.12.001
Precision management of severe coronary artery calcification with concomitant left ventricular outflow tract obstruction: a case report
Qi, W., Zhang, Y., Wang, Z., Hou, K., Li, T., & Cong, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1795850
Genetik der Kardiomyopathien – Was junge Kardiolog:innen wissen müssen
Broezel, A., & Meder, B. (2026) · Die Kardiologie · doi:10.1007/s12181-026-00809-4
Hypertrophic cardiomyopathy in pediatric practice: a discussion on the association with COVID-19
Sokolovskaya, V. V., Литвинова, А. А., Ovchinnikova, O. V., Sorochkina, M. Y., & Kristalinskaya, T. V. (2026) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2026-25-1-33-36
Deep Learning-Based Single-View Echocardiographic Analysis for Prediction of Left Ventricular Outflow Tract Gradient Elevation After Transcatheter Aortic Valve ReplacementPreprint
Choi, J.-W., Park, J., Yoon, Y. E., Kim, J., Jeon, J., Jang, Y., Lee, S.-A., Bak, M., Choi, H., Hwang, I., et al. (2026) · medRxiv · doi:10.64898/2026.03.27.26349567
Self-citation
Integrating Genetic Counseling in Cardiology Clinics: From Guidelines to Practice
Sanoudou, D., Vakrou, S., & Frogoudaki, A. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48695
Treatment strategies for hypertrophic cardiomyopathy based on anatomical variant
Semenova, Y. V., Миронков, Б. Л., & Izotov, D. A. (2026) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2026-1-85-97

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks